Human Multiple Myeloma Cells Are Sensitized to Topoisomerase II Inhibitors by CRM1 Inhibition
Open Access
- 31 August 2009
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 69 (17), 6899-6905
- https://doi.org/10.1158/0008-5472.can-09-0484
Abstract
Topoisomerase IIα (topo IIα) is exported from the nucleus of human myeloma cells by a CRM1-dependent mechanism at cellular densities similar to those found in patient bone marrow. When topo IIα is trafficked to the cytoplasm, it is not in contact with the DNA; thus, topo IIα inhibitors are unable to induce DNA-cleavable complexes and cell death. Using a CRM1 inhibitor or a CRM1-specific small interfering RNA (siRNA), we were able to block nuclear export of topo IIα as shown by immunofluorescence microscopy. Human myeloma cell lines and patient myeloma cells isolated from bone marrow were treated with a CRM1 inhibitor or CRM1-specific siRNA and exposed to doxorubicin or etoposide at high cell densities. CRM1-treated cell lines or myeloma patient cells were 4-fold more sensitive to topo II poisons as determined by an activated caspase assay. Normal cells were not significantly affected by CRM1-topo II inhibitor combination treatment. Cell death was correlated with increased DNA double-strand breaks as shown by the comet assay. Band depletion assays of CRM1 inhibitor–exposed myeloma cells showed increased topo IIα covalently bound to DNA. Topo IIα knockdown by a topo IIα–specific siRNA abrogated the CRM1-topo II therapy synergistic effect. These results suggest that blocking topo IIα nuclear export sensitizes myeloma cells to topo II inhibitors. This method of sensitizing myeloma cells suggests a new therapeutic approach to multiple myeloma. [Cancer Res 2009;69(17):6899–905]Keywords
This publication has 32 references indexed in Scilit:
- Identification of Nuclear Export Inhibitors with Potent Anticancer Activity In vivoCancer Research, 2009
- Both carboxy-terminus NES motif and mutated tryptophan(s) are crucial for aberrant nuclear export of nucleophosmin leukemic mutants in NPMc+ AMLBlood, 2006
- Cell Adhesion to Fibronectin (CAM-DR) Influences Acquired Mitoxantrone Resistance in U937 CellsCancer Research, 2006
- The FA/BRCA pathway is involved in melphalan-induced DNA interstrand cross-link repair and accounts for melphalan resistance in multiple myeloma cellsBlood, 2005
- Ratjadone and leptomycin B block CRM1‐dependent nuclear export by identical mechanismsFEBS Letters, 2004
- Human topoisomerase IIα nuclear export is mediated by two CRM-1-dependent nuclear export signalsJournal of Cell Science, 2004
- The cytoplasmic trafficking of DNA topoisomerase IIα correlates with etoposide resistance in human myeloma cellsExperimental Cell Research, 2004
- Reduction in drug-induced DNA double-strand breaks associated with β1 integrin–mediated adhesion correlates with drug resistance in U937 cellsBlood, 2001
- Cell density‐dependent VP‐16 sensitivity of leukaemic cells is accompanied by the translocation of topoisomerase IIα from the nucleus to the cytoplasmBritish Journal of Haematology, 2000
- Purification and characterization of an altered topoisomerase II from a drug-resistant Chinese hamster ovary cell lineBiochemistry, 1989